Related Experiment Video
Updated: Feb 16, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
14.0K
An enzymatic advance in nicotine cessation therapy
Song Xue1, Marsida Kallupi, Bin Zhou
1Departments of Chemistry, Immunology, Microbiology and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA. kdjanda@scripps.edu.
Chemical Communications (Cambridge, England)
|January 9, 2018
Summary
Researchers modified a nicotine-degrading enzyme (NicA2) to create NicA2-J1, which blocked nicotine from reaching the brain and reduced its psychoactive effects. This supports developing new nicotine cessation therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Neuroscience
Background:
- Nicotine addiction remains a significant public health issue.
- Pharmacokinetic strategies offer a novel approach to nicotine cessation.
- Enzyme engineering can modify drug properties for therapeutic benefit.
Purpose of the Study:
- To engineer a nicotine-degrading enzyme, NicA2, with an extended half-life for potential therapeutic use.
- To evaluate the in vivo efficacy of the engineered enzyme, NicA2-J1, in blocking nicotine's central effects.
Main Methods:
- Protein engineering by fusing an albumin binding domain to NicA2 to create NicA2-J1.
- In vivo administration of NicA2-J1 to assess its pharmacokinetic and pharmacodynamic properties.
- Evaluation of NicA2-J1's effect on brain nicotine levels and associated psychoactive effects.
Main Results:
- The engineered NicA2-J1 enzyme exhibited a significantly increased half-life.
- NicA2-J1 successfully prevented nicotine from accessing the brain in vivo.
- The blockade of brain nicotine entry by NicA2-J1 blunted nicotine's characteristic psychoactive effects.
Conclusions:
- Engineered NicA2-J1 demonstrates potential as a pharmacokinetic tool for nicotine cessation.
- Modifying enzyme half-life is a viable strategy for developing targeted therapeutics.
- These findings support the advancement of enzyme-based therapies for nicotine dependence treatment.
More Related Videos
Related Concept Videos
01:15Cholinergic Receptors: Nicotinic
5.8K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.8K
01:27CNS Depressants: Alcohol and Nicotine
1.3K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
02:22Overview of Advanced Functional Groups
30.4K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
30.4K
00:56Extraction: Advanced Methods
1.2K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.2K
01:26Group Therapy
472
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
472